Yiqin Wang
0000-0003-4714-774X
Publication & Citation Trends
Publications
0 total
Angiogenic switching in cerebral cavernous malformations driven by MAP3K3-PIK3CA synergy.
Cited by 0
Semantic Scholar
Lysine-targeting, Covalent Inhibitors of Bromodomain BD1 of BET Proteins in Live Cells and Animals.
Cited by 7
Semantic Scholar
Discovery of the novel celastrol-based PROTACs for the treatment of non-small cell lung cancer
Cited by 1
Semantic Scholar
Design, Synthesis, and Antifungal Activity of Novel Stilbene Cyclohexyl Sulfonamide Derivatives against Botrytis cinerea.
Cited by 3
Semantic Scholar
Ferroptosis resistance-related TEP1 as a novel prognostic biomarker involved in immune cell infiltration and tumour progression in glioblastoma
Cited by 0
Semantic Scholar
Design, Synthesis, and Anticancer Activity Evaluation of the New SHP2 Degraders
Cited by 1
Semantic Scholar
Identification of Key Gene Modules and Hub Genes of Glioblastoma Using Machine-learning and WGCNA Algorithm
Cited by 0
Semantic Scholar
Research Topics
Cancer-related molecular mechanisms research
(17)
Endometrial and Cervical Cancer Treatments
(17)
RNA modifications and cancer
(16)
Epigenetics and DNA Methylation
(13)
Genetic Associations and Epidemiology
(12)
Affiliations
Hebei Agricultural University
Novartis (Switzerland)
Army Medical University
Sun Yat-sen University
Queen Mary University of London